Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMEND vs EMPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMEND vs EMPAGLIFLOZIN: Safety Overview

Metric EMEND EMPAGLIFLOZIN
Total FAERS Reports 155 37,059
Deaths Reported 18 1,624
Death Rate 11.6% 4.4%
Hospitalizations 53 12,216
Average Patient Age 53.4 yrs 64.3 yrs
% Female Patients N/A 46.0%
FDA Approval Date N/A Aug 1, 2014
Manufacturer N/A Cardinal Health 107, LLC
Route N/A ORAL
Marketing Status N/A Prescription